DUBLIN, Ohio -- Cardinal Health, a global provider of products and services that improve the safety and productivity of healthcare, today announced it has completed the acquisition of assets of privately held Enturia, Inc., the manufacturer of infection prevention products sold under the ChloraPrep(R) brand name.
ChloraPrep(R) brand products are used widely in U.S. hospitals and surgery centers as a patient preoperative skin preparation to help prevent bloodstream and surgical site infections, two of the most common types of healthcare-associated infections (HAIs) among surgery patients. The products use proprietary disposable applicators to deliver a clinically preferred concentration of chlorhexidine gluconate (CHG) that penetrates the first five cell layers of the skin to help reduce skin-dwelling microorganisms that cause infections. The applicator design eliminates direct hand-to-patient contact, helping prevent cross-contamination.
The ChloraPrep(R) product line expands the company's offerings that help providers lower infection rates. Cardinal Health's infection prevention portfolio ranges from MedMined(TM) electronic infection surveillance services to medical products and surgical apparel. Cardinal Health plans to accelerate sales of ChloraPrep(R) products to both hospital and alternate-care customers through its U.S. and international sales networks.
Source: Cardinal Health